Summary: Race, Memory, and Medicine
The Unequal Landscape of Alzheimer's in America
Her mother had been “forgetful” for years. The primary care doctor said it was normal aging. By the time a specialist finally saw her, the diagnosis was moderate Alzheimer’s. The new drugs were not an option. The window had closed. The daughter, a Black woman in Atlanta, asked: “Would they have caught it earlier if she were white?” The research says probably yes.
Black Americans are roughly twice as likely to develop Alzheimer’s as white Americans. Hispanic Americans approximately 1.5 times. Genetics explains only a fraction. The rest is written in social determinants: decades of unequal access to healthcare, chronic stress from discrimination, higher prevalence of cardiovascular risk factors shaped by the neighborhoods where Black Americans were permitted to live through redlining and its successors. The weathering hypothesis, developed by Arline Geronimus, documents how the cumulative burden of discrimination ages the body faster than calendar years. Structural racism is not separate from Alzheimer’s risk. It is a pathway to it.
Higher risk would be concerning enough. Black and Hispanic patients are also diagnosed later, when fewer options remain. Studies consistently show later-stage diagnoses in these communities, driven by cultural factors, provider bias in screening and referral, and language barriers in cognitive testing. Late diagnosis forecloses the treatment window.
The new drugs require infrastructure that is unequally distributed: PET scanners, infusion centers, experienced neurologists, all concentrated in academic medical centers and affluent areas. Black Americans represent roughly 5 to 7% of Alzheimer’s clinical trial participants despite bearing the highest disease burden. The legacy of Tuskegee and Henrietta Lacks means distrust of medical research is not irrational; it is a rational response to documented exploitation.
Recent efforts are underway: community-based trial recruitment, trusted messengers in churches and barbershops, culturally adapted caregiver support. These are steps. They are not sufficient. You cannot fix Alzheimer’s disparities without fixing healthcare disparities, and you cannot fix those without addressing the housing, environmental, education, and economic policy that shape them.
The disease is biological. The disparity is political. Only political will can close the gap.